Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)

NCT05218668 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Fasudil (WP-0512)
DRUG: Fasudil (WP-0512)

Sponsor

Woolsey Pharmaceuticals